Primary Tumor Resection Provides No OS Benefit in Asymptomatic Colorectal Cancer With Unresectable Metastases
The data suggest that primary tumor resection does not improve overall survival, but chemotherapy does.
The data suggest that primary tumor resection does not improve overall survival, but chemotherapy does.
Researchers identified socioeconomic and demographic factors related to oral treatment adherence in patients with multiple myeloma.
The program was associated with significant reductions in patients’ length of stay in the ICU, ICU mortality, and in-hospital mortality.
The expansion of Medicaid eligibility was associated with a nearly 3-fold increase in the proportion of Medicaid-covered patients enrolled in cancer treatment trials.
The G8 and CARG chemotherapy toxicity assessment tools were found to predict early hospitalization/ER visits and death in older patients with cancer.
Researchers identified demographic and socioeconomic factors associated with differences in staging of non-small cell lung cancer at initial presentation.
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.
Patients who received denosumab had a significant improvement in disease-free survival and bone metastasis-free survival.
The incidence of advanced lung cancer declined by 3 cases per 100,000 people per year in 2015-2018 relative to 2004-2014.
The overall response rate was 66.7%, and the median duration of response was 17.5 months.